The GMZ2 malaria vaccine: from concept to efficacy in humans
Introduction: GMZ2 is a recombinant protein consisting of conserved domains of GLURP and MSP3, two asexual blood-stage antigens of Plasmodium falciparum, and is designed with the aim of mimicking naturally acquired anti-malarial immunity. The rationale for combining these two antigens is based on a...
Main Authors: | Michael Theisen, Bright Adu, Benjamin Mordmüller, Subhash Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-09-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2017.1355246 |
Similar Items
-
msp1, msp2, and glurp genotyping to differentiate Plasmodium falciparum recrudescence from reinfections during prevention of reestablishment phase, Sri Lanka, 2014–2019
by: Kumudunayana T. Gunasekera, et al.
Published: (2024-01-01) -
B-Cell Epitope Mapping of the <i>Plasmodium falciparum</i> Malaria Vaccine Candidate GMZ2.6c in a Naturally Exposed Population of the Brazilian Amazon
by: Barbara de Oliveira Baptista, et al.
Published: (2023-02-01) -
Genetic polymorphisms in the glutamate-rich protein of Plasmodium falciparum field isolates from a malaria-endemic area of Brazil
by: Lilian Rose Pratt-Riccio, et al.
Published: (2013-06-01) -
Antibodies against the Plasmodium falciparum glutamate-rich protein from naturally exposed individuals living in a Brazilian malaria-endemic area can inhibit in vitro parasite growth
by: Lilian Rose Pratt-Riccio, et al.
Published: (2011-08-01) -
CRX-527 as a candidate adjuvant in a recombinant BCG-based malaria vaccine
by: Nor Munirah Zakaria, et al.
Published: (2024-01-01)